Investments
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
Ionis stock jumped Thursday after a Food and Drug Administration panel offered a mixed view of its Biogen (BIIB)-partnered treatment for a deadly neurodegenerative condition. The companies are hoping to win approval for tofersen, a […]